42 /100
MEDIUM RISK
Score updated May 30, 2026

DYAI — Dyadic International, Inc. Dilution Risk Tracker

Track DYAI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DYAI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
27
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
43%
🔄 Reverse Split 55%
• 50-day avg $0.80 below $1 exchange minimum
📉 Score Deterioration 40%
• Score rose 21 points recently (worsening)
💰 Capital Raise 18%
• Active ATM program with $4M remaining capacity
🔔 Track DYAI — Get forecast alerts →

💹 Market Data

Market Cap$29.44M
Shares Outstanding36.44M
Float27.37M
Cash$5.61M
Debt$5.05M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 5.4% shares (2025Q4 vs prior)
38 institutional holders · 5.57M shares
#1 Apis Capital Advisors, LLC 1.49M shares
#2 VANGUARD GROUP INC 915.0K shares
#3 CHAPIN DAVIS, INC. 888.0K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest72.8K
Days to Cover1.0
% of Float0.3%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2024
8-K 8K EVENT Mar 06, 2026
424B5 ATM Mar 06, 2026
4 INSIDER TRANSACTION Jan 06, 2026
4 INSIDER TRANSACTION Jan 06, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track DYAI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DYAI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for DYAI
📊 DYAI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 DYAI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.